

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle cell cellular homeostasis (GO:0046716) | 7.85573890 |
| 2 | synaptonemal complex assembly (GO:0007130) | 7.29844113 |
| 3 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 7.24000102 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.84698750 |
| 5 | synapsis (GO:0007129) | 6.73610097 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.63299907 |
| 7 | chromosome organization involved in meiosis (GO:0070192) | 6.49401028 |
| 8 | synaptonemal complex organization (GO:0070193) | 6.19677253 |
| 9 | muscle filament sliding (GO:0030049) | 5.96215268 |
| 10 | actin-myosin filament sliding (GO:0033275) | 5.96215268 |
| 11 | DNA strand renaturation (GO:0000733) | 5.62298410 |
| 12 | myoblast fusion (GO:0007520) | 5.53126083 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.51503970 |
| 14 | male meiosis I (GO:0007141) | 5.36537186 |
| 15 | syncytium formation by plasma membrane fusion (GO:0000768) | 5.29520633 |
| 16 | actin-mediated cell contraction (GO:0070252) | 5.24418204 |
| 17 | DNA synthesis involved in DNA repair (GO:0000731) | 5.16245127 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 4.88266377 |
| 19 | plasma membrane fusion (GO:0045026) | 4.85313924 |
| 20 | meiosis I (GO:0007127) | 4.76463649 |
| 21 | syncytium formation (GO:0006949) | 4.69699989 |
| 22 | meiotic nuclear division (GO:0007126) | 4.57840604 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.57480097 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.52417007 |
| 25 | regulation of striated muscle contraction (GO:0006942) | 4.41973186 |
| 26 | skeletal muscle contraction (GO:0003009) | 4.40019634 |
| 27 | piRNA metabolic process (GO:0034587) | 4.18747032 |
| 28 | endosome to melanosome transport (GO:0035646) | 4.16660089 |
| 29 | endosome to pigment granule transport (GO:0043485) | 4.16660089 |
| 30 | regulation of sarcomere organization (GO:0060297) | 4.08572893 |
| 31 | positive regulation of microtubule polymerization (GO:0031116) | 3.95197281 |
| 32 | actin filament-based movement (GO:0030048) | 3.94007381 |
| 33 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.92659283 |
| 34 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.92659283 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.86998235 |
| 36 | heart process (GO:0003015) | 3.86332543 |
| 37 | heart contraction (GO:0060047) | 3.86332543 |
| 38 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.83813042 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 3.72861773 |
| 40 | blood vessel maturation (GO:0001955) | 3.67452269 |
| 41 | negative regulation of growth of symbiont in host (GO:0044130) | 3.60812609 |
| 42 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.60812609 |
| 43 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.60812609 |
| 44 | regulation of growth of symbiont in host (GO:0044126) | 3.60812609 |
| 45 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.45223606 |
| 46 | macrophage differentiation (GO:0030225) | 3.40511492 |
| 47 | protein maturation by protein folding (GO:0022417) | 3.38683205 |
| 48 | protein-chromophore linkage (GO:0018298) | 3.35823456 |
| 49 | meiotic cell cycle process (GO:1903046) | 3.31118178 |
| 50 | negative regulation of monooxygenase activity (GO:0032769) | 3.31058324 |
| 51 | musculoskeletal movement (GO:0050881) | 3.28734965 |
| 52 | multicellular organismal movement (GO:0050879) | 3.28734965 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.27116164 |
| 54 | positive regulation of myotube differentiation (GO:0010831) | 3.21375441 |
| 55 | neuromuscular synaptic transmission (GO:0007274) | 3.19034132 |
| 56 | negative regulation of interleukin-8 production (GO:0032717) | 3.16605535 |
| 57 | male meiosis (GO:0007140) | 3.08291284 |
| 58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.07198480 |
| 59 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.99623008 |
| 60 | regulation of translation in response to stress (GO:0043555) | 2.98891835 |
| 61 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.98522663 |
| 62 | plasma membrane repair (GO:0001778) | 2.97540576 |
| 63 | neutrophil mediated immunity (GO:0002446) | 2.96824599 |
| 64 | establishment of integrated proviral latency (GO:0075713) | 2.92711825 |
| 65 | DNA methylation involved in gamete generation (GO:0043046) | 2.92454043 |
| 66 | single strand break repair (GO:0000012) | 2.91832375 |
| 67 | negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736) | 2.89538620 |
| 68 | reciprocal DNA recombination (GO:0035825) | 2.88596415 |
| 69 | reciprocal meiotic recombination (GO:0007131) | 2.88596415 |
| 70 | I-kappaB phosphorylation (GO:0007252) | 2.86676379 |
| 71 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.86631846 |
| 72 | glycosphingolipid catabolic process (GO:0046479) | 2.85339127 |
| 73 | cardiac myofibril assembly (GO:0055003) | 2.80353226 |
| 74 | positive regulation of interferon-alpha production (GO:0032727) | 2.80328891 |
| 75 | histone H3-K36 demethylation (GO:0070544) | 2.77735968 |
| 76 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76415625 |
| 77 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76415625 |
| 78 | modulation by symbiont of host immune response (GO:0052553) | 2.76415625 |
| 79 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76415625 |
| 80 | modulation by symbiont of host defense response (GO:0052031) | 2.76415625 |
| 81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76415625 |
| 82 | sarcomere organization (GO:0045214) | 2.76048783 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.74436910 |
| 84 | striated muscle contraction (GO:0006941) | 2.73468257 |
| 85 | female mating behavior (GO:0060180) | 2.71856556 |
| 86 | negative regulation of cell killing (GO:0031342) | 2.71463058 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.71463058 |
| 88 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.70018419 |
| 89 | cytokine biosynthetic process (GO:0042089) | 2.69411246 |
| 90 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68778081 |
| 91 | regulation of cardiac muscle contraction (GO:0055117) | 2.63991313 |
| 92 | germinal center formation (GO:0002467) | 2.63778927 |
| 93 | response to peptidoglycan (GO:0032494) | 2.62645476 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59006936 |
| 95 | regulation of podosome assembly (GO:0071801) | 2.58722526 |
| 96 | nerve growth factor signaling pathway (GO:0038180) | 2.55438903 |
| 97 | negative regulation of muscle hypertrophy (GO:0014741) | 2.53102147 |
| 98 | regulation of relaxation of muscle (GO:1901077) | 2.51542419 |
| 99 | establishment of viral latency (GO:0019043) | 2.51214848 |
| 100 | substrate-dependent cell migration (GO:0006929) | 2.50746628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 5.42299620 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.88170017 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.37508053 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14024642 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.06081577 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97404781 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90391140 |
| 8 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.64996679 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59224827 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55199628 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.51941708 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.43887299 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40247992 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29909030 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26611512 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19640007 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08412471 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07196049 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05478850 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04438497 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04098632 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03922665 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97676631 |
| 24 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.94689004 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88174934 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85898566 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77313016 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76355009 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75814669 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69520720 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.62287661 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61296580 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60787449 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57709768 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57225853 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54648331 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.53500103 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48342322 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.48056769 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44897251 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44510511 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.43696564 |
| 43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.41371041 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.41371041 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39159109 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39101527 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36904272 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34636802 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31828576 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30125275 |
| 51 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29769950 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29327759 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29095282 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27234721 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25935083 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23466400 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21672815 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20715887 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19985110 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19251617 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.18350962 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14917785 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13086135 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12988372 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12159277 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09267546 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08305791 |
| 68 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06835532 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06197359 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05313182 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03611823 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00054253 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96674501 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95554985 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95425638 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95061339 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91985655 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91813764 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89447343 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89192584 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86876105 |
| 82 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86781041 |
| 83 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86190097 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.86029327 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83963330 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83317490 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.83095939 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81626216 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81386252 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81023926 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80290566 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80214013 |
| 93 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79596171 |
| 94 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79325980 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78757063 |
| 96 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.78450584 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.77933749 |
| 98 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.77134430 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76733575 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.76576808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 7.23164685 |
| 2 | MP0000749_muscle_degeneration | 5.03912962 |
| 3 | MP0004510_myositis | 3.81575150 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.41352044 |
| 5 | MP0002736_abnormal_nociception_after | 3.19602345 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.11508824 |
| 7 | MP0005451_abnormal_body_composition | 2.64198996 |
| 8 | MP0008058_abnormal_DNA_repair | 2.62263783 |
| 9 | MP0001849_ear_inflammation | 2.45209533 |
| 10 | MP0000751_myopathy | 2.39398852 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.38960793 |
| 12 | MP0003279_aneurysm | 2.10409777 |
| 13 | MP0003436_decreased_susceptibility_to | 1.98729110 |
| 14 | MP0008789_abnormal_olfactory_epithelium | 1.96841049 |
| 15 | MP0004233_abnormal_muscle_weight | 1.88067610 |
| 16 | MP0004084_abnormal_cardiac_muscle | 1.80978979 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 1.71628739 |
| 18 | MP0002419_abnormal_innate_immunity | 1.71384754 |
| 19 | MP0005248_abnormal_Harderian_gland | 1.62719272 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.60584252 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.52016546 |
| 22 | MP0008004_abnormal_stomach_pH | 1.50709181 |
| 23 | MP0005387_immune_system_phenotype | 1.50661043 |
| 24 | MP0001790_abnormal_immune_system | 1.50661043 |
| 25 | MP0001851_eye_inflammation | 1.48979439 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.47147258 |
| 27 | MP0006082_CNS_inflammation | 1.46658633 |
| 28 | MP0006054_spinal_hemorrhage | 1.45893170 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.45765810 |
| 30 | MP0003724_increased_susceptibility_to | 1.44943572 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.43363023 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.40876066 |
| 33 | MP0004484_altered_response_of | 1.40215423 |
| 34 | MP0005025_abnormal_response_to | 1.35814901 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.32566001 |
| 36 | MP0005499_abnormal_olfactory_system | 1.30441715 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.30441715 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.29747351 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.28446195 |
| 40 | MP0003868_abnormal_feces_composition | 1.26753618 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.26458153 |
| 42 | MP0003448_altered_tumor_morphology | 1.25305574 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.24375548 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.23320415 |
| 45 | MP0003011_delayed_dark_adaptation | 1.19249118 |
| 46 | MP0001958_emphysema | 1.18710781 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.18659007 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.17261496 |
| 49 | MP0002269_muscular_atrophy | 1.15311590 |
| 50 | MP0002723_abnormal_immune_serum | 1.13987096 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.12900733 |
| 52 | MP0001819_abnormal_immune_cell | 1.11582420 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.10751471 |
| 54 | MP0003828_pulmonary_edema | 1.10579789 |
| 55 | MP0003091_abnormal_cell_migration | 1.09916584 |
| 56 | MP0001915_intracranial_hemorrhage | 1.09896415 |
| 57 | MP0009785_altered_susceptibility_to | 1.09207541 |
| 58 | MP0001800_abnormal_humoral_immune | 1.08441948 |
| 59 | MP0002405_respiratory_system_inflammati | 1.05054822 |
| 60 | MP0004883_abnormal_blood_vessel | 1.03875187 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00692741 |
| 62 | MP0002398_abnormal_bone_marrow | 0.98111359 |
| 63 | MP0000015_abnormal_ear_pigmentation | 0.97840509 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.96463387 |
| 65 | MP0000685_abnormal_immune_system | 0.94803608 |
| 66 | MP0000747_muscle_weakness | 0.94364875 |
| 67 | MP0001533_abnormal_skeleton_physiology | 0.93872613 |
| 68 | MP0004087_abnormal_muscle_fiber | 0.92596767 |
| 69 | MP0000716_abnormal_immune_system | 0.91898336 |
| 70 | MP0002933_joint_inflammation | 0.91495307 |
| 71 | MP0000490_abnormal_crypts_of | 0.90962593 |
| 72 | MP0001845_abnormal_inflammatory_respons | 0.90464665 |
| 73 | MP0003646_muscle_fatigue | 0.90081717 |
| 74 | MP0008260_abnormal_autophagy | 0.89997565 |
| 75 | MP0001663_abnormal_digestive_system | 0.88690567 |
| 76 | MP0002722_abnormal_immune_system | 0.86106484 |
| 77 | MP0000343_altered_response_to | 0.84541347 |
| 78 | MP0005310_abnormal_salivary_gland | 0.83669488 |
| 79 | MP0002106_abnormal_muscle_physiology | 0.82855250 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.82738122 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.82450374 |
| 82 | MP0005671_abnormal_response_to | 0.82320724 |
| 83 | MP0005330_cardiomyopathy | 0.82256837 |
| 84 | MP0008469_abnormal_protein_level | 0.81089317 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.81067748 |
| 86 | MP0005165_increased_susceptibility_to | 0.80985668 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.80926373 |
| 88 | MP0002972_abnormal_cardiac_muscle | 0.77771830 |
| 89 | MP0003075_altered_response_to | 0.75659899 |
| 90 | MP0005023_abnormal_wound_healing | 0.74898297 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.74019901 |
| 92 | MP0000516_abnormal_urinary_system | 0.74019901 |
| 93 | MP0002429_abnormal_blood_cell | 0.73807130 |
| 94 | MP0009764_decreased_sensitivity_to | 0.73779682 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.72507801 |
| 96 | MP0008007_abnormal_cellular_replicative | 0.72408918 |
| 97 | MP0003385_abnormal_body_wall | 0.71107945 |
| 98 | MP0001756_abnormal_urination | 0.70725483 |
| 99 | MP0009763_increased_sensitivity_to | 0.68322282 |
| 100 | MP0005193_abnormal_anterior_eye | 0.67635377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 2 muscle fiber atrophy (HP:0003554) | 7.67807717 |
| 2 | Muscle fiber atrophy (HP:0100295) | 7.22445288 |
| 3 | Popliteal pterygium (HP:0009756) | 6.69107851 |
| 4 | Amniotic constriction ring (HP:0009775) | 6.24907333 |
| 5 | Abnormality of placental membranes (HP:0011409) | 6.24907333 |
| 6 | Aplasia of the musculature (HP:0100854) | 6.15579006 |
| 7 | Fatigable weakness (HP:0003473) | 5.13828775 |
| 8 | Abnormality of the neuromuscular junction (HP:0003398) | 5.13828775 |
| 9 | Fetal akinesia sequence (HP:0001989) | 4.99668237 |
| 10 | Weak cry (HP:0001612) | 4.91552944 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 4.71723813 |
| 12 | Gowers sign (HP:0003391) | 4.36944736 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.14940129 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.93038247 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 3.92242638 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.87797976 |
| 17 | Subaortic stenosis (HP:0001682) | 3.87797976 |
| 18 | Malignant hyperthermia (HP:0002047) | 3.85521204 |
| 19 | Sudden death (HP:0001699) | 3.75705194 |
| 20 | Nemaline bodies (HP:0003798) | 3.75512815 |
| 21 | Exercise-induced myalgia (HP:0003738) | 3.72411524 |
| 22 | Easy fatigability (HP:0003388) | 3.68593220 |
| 23 | Akinesia (HP:0002304) | 3.65585102 |
| 24 | Dyschromatopsia (HP:0007641) | 3.64299024 |
| 25 | Subacute progressive viral hepatitis (HP:0006572) | 3.53780337 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.53767117 |
| 27 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.36123453 |
| 28 | Deformed tarsal bones (HP:0008119) | 3.29663035 |
| 29 | Enlarged epiphyses (HP:0010580) | 3.17807332 |
| 30 | Thin ribs (HP:0000883) | 3.15998604 |
| 31 | Round ear (HP:0100830) | 3.09404058 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.97957104 |
| 33 | Viral hepatitis (HP:0006562) | 2.87264021 |
| 34 | Cystic hygroma (HP:0000476) | 2.81739966 |
| 35 | Late onset (HP:0003584) | 2.76035938 |
| 36 | Hypoplastic heart (HP:0001961) | 2.75993388 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 2.73405080 |
| 38 | Bulbar palsy (HP:0001283) | 2.71978641 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.58614215 |
| 40 | Exercise-induced muscle cramps (HP:0003710) | 2.58569354 |
| 41 | Neck muscle weakness (HP:0000467) | 2.43140182 |
| 42 | Limb-girdle muscle atrophy (HP:0003797) | 2.37035384 |
| 43 | Generalized muscle weakness (HP:0003324) | 2.32385048 |
| 44 | Pterygium (HP:0001059) | 2.32102899 |
| 45 | Calcaneovalgus deformity (HP:0001848) | 2.31517363 |
| 46 | Horizontal nystagmus (HP:0000666) | 2.24134342 |
| 47 | Chest pain (HP:0100749) | 2.18963826 |
| 48 | Type 1 muscle fiber predominance (HP:0003803) | 2.18864382 |
| 49 | Ovoid vertebral bodies (HP:0003300) | 2.16714594 |
| 50 | Thin bony cortex (HP:0002753) | 2.13416978 |
| 51 | Poor suck (HP:0002033) | 2.09785018 |
| 52 | Loss of speech (HP:0002371) | 2.08463699 |
| 53 | Left ventricular hypertrophy (HP:0001712) | 2.05133695 |
| 54 | Micronodular cirrhosis (HP:0001413) | 2.02426436 |
| 55 | Abnormality of dentin (HP:0010299) | 1.99581841 |
| 56 | Agammaglobulinemia (HP:0004432) | 1.98550227 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 1.97917481 |
| 58 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.94343166 |
| 59 | Recurrent abscess formation (HP:0002722) | 1.92107523 |
| 60 | Spontaneous abortion (HP:0005268) | 1.89928827 |
| 61 | Stomatitis (HP:0010280) | 1.89380507 |
| 62 | Diminished movement (HP:0002374) | 1.87869485 |
| 63 | Spontaneous hematomas (HP:0007420) | 1.85626732 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 1.85148975 |
| 65 | Trismus (HP:0000211) | 1.81622801 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 1.77650123 |
| 67 | Abnormality of macrophages (HP:0004311) | 1.77480808 |
| 68 | Capillary hemangiomas (HP:0005306) | 1.76495151 |
| 69 | Mucopolysacchariduria (HP:0008155) | 1.73533183 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73533183 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 1.72313459 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.72313459 |
| 73 | Periodontitis (HP:0000704) | 1.72057408 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70383229 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70383229 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70383229 |
| 77 | Broad distal phalanx of finger (HP:0009836) | 1.69573603 |
| 78 | Slender build (HP:0001533) | 1.65667601 |
| 79 | Lipoatrophy (HP:0100578) | 1.64210150 |
| 80 | Cervical subluxation (HP:0003308) | 1.63390779 |
| 81 | Nonprogressive disorder (HP:0003680) | 1.63182185 |
| 82 | Recurrent pneumonia (HP:0006532) | 1.63141296 |
| 83 | Metatarsus adductus (HP:0001840) | 1.62356048 |
| 84 | Adactyly (HP:0009776) | 1.61860589 |
| 85 | Sepsis (HP:0100806) | 1.61671067 |
| 86 | Dysostosis multiplex (HP:0000943) | 1.61050739 |
| 87 | Limb ataxia (HP:0002070) | 1.59857470 |
| 88 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.58546116 |
| 89 | Combined immunodeficiency (HP:0005387) | 1.56203423 |
| 90 | Cellulitis (HP:0100658) | 1.56034351 |
| 91 | Hip contracture (HP:0003273) | 1.54380757 |
| 92 | Epidermoid cyst (HP:0200040) | 1.51940576 |
| 93 | Papillary thyroid carcinoma (HP:0002895) | 1.50419625 |
| 94 | Dilated cardiomyopathy (HP:0001644) | 1.48680543 |
| 95 | Arthrogryposis multiplex congenita (HP:0002804) | 1.48608426 |
| 96 | Facial diplegia (HP:0001349) | 1.48157501 |
| 97 | Eczematoid dermatitis (HP:0000976) | 1.47121307 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 1.45468336 |
| 99 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.44402155 |
| 100 | Azoospermia (HP:0000027) | 1.43953003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.88245235 |
| 2 | BRD4 | 3.28370664 |
| 3 | AKT3 | 3.25132598 |
| 4 | PIK3CG | 3.08551815 |
| 5 | VRK2 | 3.04056279 |
| 6 | DDR2 | 2.65867129 |
| 7 | ERN1 | 2.61956036 |
| 8 | BCKDK | 2.46155002 |
| 9 | MAP3K14 | 2.16908265 |
| 10 | NEK9 | 2.12123876 |
| 11 | CDK6 | 1.99227340 |
| 12 | PDK2 | 1.89895665 |
| 13 | BLK | 1.83704029 |
| 14 | STK38 | 1.74330109 |
| 15 | MAP3K10 | 1.71434552 |
| 16 | PRKD2 | 1.71423816 |
| 17 | PLK2 | 1.69077185 |
| 18 | CDK12 | 1.67766904 |
| 19 | MAP3K5 | 1.66572246 |
| 20 | RIPK4 | 1.58942152 |
| 21 | MARK1 | 1.58118113 |
| 22 | CDK19 | 1.55657347 |
| 23 | CSK | 1.48371011 |
| 24 | MARK2 | 1.42899182 |
| 25 | LIMK1 | 1.41785269 |
| 26 | MUSK | 1.34499045 |
| 27 | CSNK1G2 | 1.33494609 |
| 28 | IRAK3 | 1.33168973 |
| 29 | MAP3K7 | 1.33010461 |
| 30 | MAPK15 | 1.29410086 |
| 31 | MAP3K11 | 1.20942519 |
| 32 | CSNK1G1 | 1.17376492 |
| 33 | MAPK11 | 1.17019243 |
| 34 | MAPK4 | 1.15684595 |
| 35 | MAP3K9 | 1.15317501 |
| 36 | PKN2 | 1.09072505 |
| 37 | CAMKK2 | 1.08605431 |
| 38 | CAMK1 | 1.06301249 |
| 39 | SGK2 | 1.05612114 |
| 40 | MAP2K3 | 1.04121991 |
| 41 | PRPF4B | 1.03921497 |
| 42 | SGK3 | 1.01818901 |
| 43 | SMG1 | 1.00573407 |
| 44 | EIF2AK3 | 0.99529834 |
| 45 | BTK | 0.95745733 |
| 46 | CSNK1A1L | 0.95382909 |
| 47 | CSNK1G3 | 0.94852425 |
| 48 | CDK9 | 0.92199746 |
| 49 | JAK3 | 0.90958786 |
| 50 | RPS6KA4 | 0.90155851 |
| 51 | CDK4 | 0.88447788 |
| 52 | MAPK7 | 0.86733357 |
| 53 | FES | 0.85664996 |
| 54 | CAMK4 | 0.85508362 |
| 55 | SIK1 | 0.81917618 |
| 56 | PTK2B | 0.81457720 |
| 57 | IRAK4 | 0.78406574 |
| 58 | GRK6 | 0.77802982 |
| 59 | TAOK2 | 0.74906180 |
| 60 | NEK6 | 0.73826316 |
| 61 | GRK7 | 0.70882813 |
| 62 | SIK3 | 0.70654381 |
| 63 | DYRK1B | 0.70038525 |
| 64 | TYK2 | 0.68106636 |
| 65 | MAP3K3 | 0.67591503 |
| 66 | JAK1 | 0.67540119 |
| 67 | CDK8 | 0.66003945 |
| 68 | TESK2 | 0.65451339 |
| 69 | TIE1 | 0.62917108 |
| 70 | CSF1R | 0.62504786 |
| 71 | SGK494 | 0.61207588 |
| 72 | SGK223 | 0.61207588 |
| 73 | VRK1 | 0.59078752 |
| 74 | YES1 | 0.58752286 |
| 75 | EGFR | 0.57799665 |
| 76 | MAPK12 | 0.57522579 |
| 77 | MELK | 0.57397258 |
| 78 | SYK | 0.57383103 |
| 79 | NME1 | 0.55838327 |
| 80 | FLT3 | 0.55837262 |
| 81 | TXK | 0.53131715 |
| 82 | MAP4K1 | 0.53000553 |
| 83 | HCK | 0.52526784 |
| 84 | ZAP70 | 0.51327216 |
| 85 | PDPK1 | 0.51326743 |
| 86 | TAOK1 | 0.50992756 |
| 87 | TAOK3 | 0.50961666 |
| 88 | EEF2K | 0.50144528 |
| 89 | TBK1 | 0.47356880 |
| 90 | PDGFRB | 0.47283470 |
| 91 | PAK4 | 0.46282507 |
| 92 | MOS | 0.42702124 |
| 93 | TTN | 0.42407628 |
| 94 | JAK2 | 0.41424586 |
| 95 | PKN1 | 0.37622170 |
| 96 | LYN | 0.35874650 |
| 97 | LRRK2 | 0.35195995 |
| 98 | NUAK1 | 0.34791266 |
| 99 | GSK3A | 0.34436471 |
| 100 | IKBKE | 0.34347015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.79464994 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.69126143 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55222495 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.53546095 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18265564 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.16697393 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.08852245 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.08155399 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.07560892 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07338561 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98916068 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.88902793 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.79160631 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.75815603 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.72359556 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.64750289 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.64660583 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61621834 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.60937955 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58411471 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54670564 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48130637 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.44790759 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41762677 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37050760 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.29952660 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24723324 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21363319 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20425893 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17982907 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17651153 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13910576 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.09491488 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08346750 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08066810 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05413833 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05105199 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03282123 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02723460 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01909656 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.01731910 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01228671 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00897509 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99756883 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.99212374 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 0.98700642 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97885875 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96227291 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91535584 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90036578 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.89226403 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88562050 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88042786 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86592262 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86266862 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85726943 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84885682 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.83876259 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83834801 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 0.82197986 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79477846 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78253108 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76958291 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76270885 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.76184709 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70719210 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70310108 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.69766532 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69376968 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69240586 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69192448 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.69008745 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68788693 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68417070 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.68063192 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67797891 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67619581 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66333707 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66237675 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65548864 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.64682834 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64306245 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.63556118 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62378938 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61630813 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.60680626 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60374623 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58035297 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57915312 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56592673 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56147547 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.55552601 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.55509100 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54428531 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53116866 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52746705 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52648433 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48248936 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47271448 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46277660 |

